August is National Immunization Awareness Month
This is timely since our residents and responsible parties received information in the mail from ACMCC recently regarding the new availability of a 2nd type of pneumococcal vaccine. The current 2 types of pneumococcal vaccines are: pneumococcal conjugate vaccine (PCV13 or Prevnar 13®) and pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax®).
PCV13 is recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors.
PPSV is recommended for all adults who are 65 years or older and for people 2 through 64 years old who are at high risk for pneumococcal disease.
Pneumonia, an infection of the lungs, needlessly affects millions of people worldwide each year. Pneumonia infections can often be prevented and can usually be treated. Each year in the United States, about 1 million people have to seek care in a hospital due to pneumonia, and about 50,000 people die from the disease. Most of the people affected by pneumonia in the United States are adults. There are vaccines that help prevent infection by some of the bacteria and viruses that can cause pneumonia.
For more information regarding the pneumococcal vaccines or other vaccinations, please visit www.cdc.gov or contact Tammy Nieuwenhuis, Director of Nursing or Renee Piebenga, Education and Infection Control Coordinator with specific questions.